A ALIMENTARY TRACT AND METABOLISM

 B BLOOD AND BLOOD FORMING ORGANS

 C CARDIOVASCULAR SYSTEM

 D DERMATOLOGICALS

 G GENITO URINARY SYSTEM AND SEX HORMONES

 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

 J ANTIINFECTIVES FOR SYSTEMIC USE

 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

   L01 ANTINEOPLASTIC AGENTS

     L01A ALKYLATING AGENTS

     L01B ANTIMETABOLITES

     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS

     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES

     L01E PROTEIN KINASE INHIBITORS

       L01EA BCR-ABL tyrosine kinase inhibitors [DG:DG03161]

       L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors [DG:DG03162]

       L01EC B-Raf serine-threonine kinase (BRAF) inhibitors [DG:DG03159]

         L01EC01 Vemurafenib

         L01EC02 Dabrafenib [DG:DG00721]

         L01EC03 Encorafenib

       L01ED Anaplastic lymphoma kinase (ALK) inhibitors [DG:DG03136]

       L01EE Mitogen-activated protein kinase (MEK) inhibitors [DG:DG03137]

       L01EF Cyclin-dependent kinase (CDK) inhibitors [DG:DG03138]

       L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors [DG:DG03160]

       L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors [DG:DG03158]

       L01EJ Janus-associated kinase (JAK) inhibitors

       L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors

       L01EL Bruton's tyrosine kinase (BTK) inhibitors [DG:DG02022]

       L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors [DG:DG03139]

       L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors

       L01EX Other protein kinase inhibitors

     L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

     L01X OTHER ANTINEOPLASTIC AGENTS

   L02 ENDOCRINE THERAPY

   L03 IMMUNOSTIMULANTS

   L04 IMMUNOSUPPRESSANTS

 M MUSCULO-SKELETAL SYSTEM

 N NERVOUS SYSTEM

 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

 R RESPIRATORY SYSTEM

 S SENSORY ORGANS

 V VARIOUS